About 1,460,000 results
Open links in new tab
  1. Eli (2019 film) - Wikipedia

    Eli is a 2019 American supernatural horror film directed by Ciarán Foy from a screenplay by David Chirchirillo, Ian Goldberg, and Richard Naing, based on a story by Chirchirillo.

  2. Eli | Official Trailer | Netflix - YouTube

    As a last resort to cure their son’s auto-immune disorder, the Millers move into a sterile manor during his treatments. Eli is tormented by terrifying vision...

  3. Watch Eli | Netflix Official Site

    Endless entertainment starting at $7.99 Email address Endless entertainment starting at $7.99 Eli

  4. Eli (2019) - IMDb

    Eli: Directed by Ciarán Foy. With Charlie Shotwell, Kelly Reilly, Max Martini, Lili Taylor. A boy receiving treatment for his auto-immune disorder discovers that the house he's living in isn't as …

  5. Eli Lilly to buy Ventyx Biosciences in $1.2 billion deal

    1 day ago · Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, marking the Zepbound maker's latest push to …

  6. Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market …

    2 days ago · Key Points Eli Lilly briefly reached $1 trillion in market cap last year before retreating. The company has seen revenue soar in recent quarters thanks to its weight loss portfolio.

  7. Eli streaming: where to watch movie online? - JustWatch

    Find out how and where to watch "Eli" online on Netflix, Prime Video, and Disney+ today – including 4K and free options.

  8. Who was Eli in the Bible?

    Eli’s name in Hebrew (עֵלִי, ʿEli) conveys the idea of elevation or exaltation. He emerges in 1 Samuel as a notable spiritual and civil figure in ancient Israel.

  9. Eli (2019) | Rotten Tomatoes

    Discover reviews, ratings, and trailers for Eli (2019) on Rotten Tomatoes. Stay updated with critic and audience scores today!

  10. Eli Lilly Snags Ventyx In $1.2 Billion Deal, But These Other Biotechs ...

    1 day ago · Eli Lilly's plan to buy Ventyx for $1.2 billion benefits more than the takeover target, an analyst said Thursday.